Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$12.63 - $24.47 $3,182 - $6,166
-252 Reduced 1.41%
17,623 $416,000
Q3 2023

Oct 25, 2023

SELL
$10.86 - $17.62 $8,796 - $14,272
-810 Reduced 4.34%
17,875 $266,000
Q2 2023

Aug 07, 2023

BUY
$7.47 - $10.95 $26,413 - $38,719
3,536 Added 23.34%
18,685 $204,000
Q1 2023

May 08, 2023

BUY
$5.88 - $9.59 $89,076 - $145,278
15,149 New
15,149 $132,000
Q2 2021

Jul 30, 2021

SELL
$3.94 - $4.92 $22,201 - $27,724
-5,635 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$5.73 - $9.03 $32,288 - $50,884
5,635 New
5,635 $32,000
Q2 2020

Jul 28, 2020

SELL
$1.41 - $4.25 $5,661 - $17,063
-4,015 Closed
0 $0
Q1 2019

Apr 29, 2019

SELL
$8.16 - $13.42 $10,705 - $17,607
-1,312 Reduced 24.63%
4,015 $53,000
Q2 2018

Aug 06, 2018

BUY
$10.66 - $14.38 $56,785 - $76,602
5,327 New
5,327 $71,000

Others Institutions Holding CBAY

About CymaBay Therapeutics, Inc.


  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.